NCT06058377 · Interventional trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Overall registry status Recruiting
Phase 3
Conditions Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
Delaware Valley sites
- Bryn Mawr Hospital · Bryn Mawr, PA · Montgomery County · Recruiting
- Lankenau Medical Center · Wynnewood, PA · Montgomery County · Recruiting
- Paoli Memorial Hospital · Paoli, PA · Chester County · Recruiting
- Riddle Memorial Hospital · Media, PA · Delaware County · Recruiting
- The Cancer Institute of New Jersey Hamilton · Hamilton, NJ · Mercer County · Recruiting
First posted
Registry updated
Added to the directory